Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Let's not forget..

Milestone,

Good point. What is the fair price per share in a buy out offer when the share price is .084? I would think that most anyone not emotionally involved would consider a %100 premium more than "fair"

But even so, all the conjecture is pointless. If TPL really want to squeeze it out, they could drop all licensing let PTSC go B/K and pick up the pieces.

It all depends on what is good for the real players, not the shareholders.



Good Luck

(I) C. W.

Share
New Message
Please login to post a reply